Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP
Sponsor: Centers for Disease Control and Prevention
Summary
This randomized, double-blinded trial will assess humoral immune responses to adjuvanted, egg-based quadrivalent influenza vaccines compared to standard dose, egg-based quadrivalent influenza vaccines among healthcare personnel (HCP). The trial will be conducted at two sites in Lima, Peru during 2022 and 2023.
Official title: Randomized Controlled Trial, Double Blind, Phase III, to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among Health Care Personnel (EDUCATE)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
192
Start Date
2022-11-04
Completion Date
2026-03-31
Last Updated
2025-05-29
Healthy Volunteers
Yes
Conditions
Interventions
FLUAD Quadrivalent
0.5 mL intramuscular dose of FLUAD Quadrivalent
FluQuadri
0.5 mL intramuscular dose of FluQuadri
Locations (2)
Hospital Nacional Arzobispo Loayza
Lima, Peru
Hospital Nacional Cayetano Heredia
Lima, Peru